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In the last years high-throughput pharmacophore
screenings have been rediscovered as an effective and
rapid tool for guiding the selection of new hit com-
pounds with predefined biological activity. This renais-
sance has also been fostered by the current possibility to
generate pharmacophore hypotheses directly from crys-
tallographic, NMR or computational models of protein-
ligand complexes [1,2]. Indeed the pharmacophore
notion provides a powerful way to identify and compare
structural features across a large set of molecules and
the possibility to screen virtually millions of compounds.
At the present time pharmacophore screenings are
further stimulated by the increasing number of chemical
vendors that offer their catalogs of chemical compounds
also for this purpose.
Unfortunately, such an advantage is in many cases
blunted by the fact that an high-throughput pharmaco-
phore screening campaign takes time during the pre-
paration steps of compound libraries, e.g. preparing
ligand structures with full hydrogen, tautomers, stereoi-
somers and, most importantly, conformers. The latter
point is extremely important in the context of pharma-
cophore screenings since the matching of a ligand mole-
cule to a pharmacophore hypothesis is dependent upon
the molecular conformation of the ligand. Furthermore,
there is no specific way to predict what conformations
are the biologically active ones for a given biological tar-
get. To address these issues we have recently introduced
CoCoCo, a suite of free muticonformational databases
that can be used for such pharmacophore screenings
[3,4].
Here we will present how these ready-to-use chemical
databases, that bear multiconformational information for
each ligand, may provide a straightforward and time-
effective way to select candidate active compounds. Dif-
ferent cases will be analyzed to highlight how different
factors, e.g. pharmacophore hypotheses and conforma-
tional states, may influence the outcome of high-
throughput screenings. Finally, a proof-of-concept
experimental study that strongly supports these
approaches will be presented.
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